Role of prostacyclin synthase in carcinogenesis
Authors:
- 1 November 2017
- journal article
- conference paper
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 133, 49-52
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (23116515, 25116720)
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 39 references indexed in Scilit:
- Enzymes of the Cyclooxygenase Pathways of Prostanoid BiosynthesisChemical Reviews, 2011
- Selective PGE2 Suppression Inhibits Colon Carcinogenesis and Modifies Local Mucosal ImmunityCancer Prevention Research, 2011
- Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasisBiochemical Journal, 2009
- Prostacyclin Prevents Murine Lung Cancer Independent of the Membrane Receptor by Activation of Peroxisomal Proliferator–Activated Receptor γCancer Prevention Research, 2008
- Genetic and Epigenetic Regulation of the Human Prostacyclin Synthase Promoter in Lung Cancer Cell LinesMolecular Cancer Research, 2007
- Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progressionProceedings of the National Academy of Sciences, 2006
- Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidyOncogene, 2005
- Human Gene Encoding Prostacyclin Synthase (PTGIS): Genomic Organization, Chromosomal Localization, and Promoter ActivityGenomics, 1996
- Overexpression of Prostacyclin Synthase Inhibits Growth of Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1995
- Molecular Cloning and Expression of Human Prostacyclin SynthaseBiochemical and Biophysical Research Communications, 1994